Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy.

Results do not support initiating metformin earlier to prevent cognitive decline and, thus, may dampen enthusiasm for metformin as a potential antidementia drug. Randomized clinical trials could help clarify the relationship between metformin and cognitive decline.